Temple University's Center for Clinical Research and Translational Sciences
天普大学临床研究和转化科学中心
基本信息
- 批准号:7216471
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-22 至 2008-09-21
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Temple University is a university research center with a strong institutional commitment for high quality basic science and patient-oriented clinical research. This commitment is evident through its ongoing support of education, training, and research. Temple University has the elements needed for a Center for Clinical Research and Translational Science. To enhance translational research, Temple University needs to build upon and interrelate its basic science strengths, its clinical strengths, and its educational programs with the unique urban patient population that Temple University serves having a high prevalence of low income, minority ethnic groups.
The overall aims of the planning grant are threefold. First, to start several initiatives to further enhance and encourage multidisciplinary clinical and translational research at Temple University. Second, to formalize a new Temple University Center for Clinical and Translational Sciences. Third, to develop a competitive proposal from Temple University for a future NIH Institutional Clinical and Translational Science Award (CTSA). During the period provided by this planning grant award, Temple University will: 1) Survey and organize our resources in graduate education, postdoctoral and fellowship training, research laboratory facilities, and investigator's areas of expertise; 2) Explore our immediate and future needs in basic science, clinical, and translational research; 3) Encourage investigators in clinical and translational research and collaborative multidisciplinary research by having conferences and starting a newsletter on clinical and translational research to further inform the faculty and investigators about ongoing research projects, shared research equipment, improvements to the research infrastructure and opportunities for collaborative translational research; 4)Conceptualize the physical and personnel infrastructure to create a Center for Clinical Research and Translational Sciences structured to encourage multidisciplinary research; 5) Establish the foundation for the CTSA application - developing a comprehensive plan for the content, governance, administration and evaluation of a CTSA and discussing the organizational and cultural changes needed for its implementation to advance education, training, and research in clinical and basic sciences.
The Center will provide an academic home to enhance clinical and translational science, increase the efficiency of clinical research, train future clinical and translational scientists, and foster career development of clinical and translational scientists. This Center of Clinical Research and Translational Sciences will help to encourage the advances in biomedical sciences to be translated to patient-oriented research. The Center will provide the clinical research resources needed and take advantage of Temple University's location in an urban area serving a population with a high prevalence of minority ethnic groups, obesity, diabetes, pulmonary and cardiovascular disorders.
描述(由申请人提供):天普大学是一所大学研究中心,致力于高质量的基础科学和以患者为导向的临床研究。这一承诺通过其对教育,培训和研究的持续支持而显而易见。天普大学拥有临床研究和转化科学中心所需的要素。为了加强转化研究,坦普尔大学需要建立在其基础科学优势,临床优势和教育计划的基础上,并与坦普尔大学所服务的独特的城市患者群体相互关联,这些患者群体具有低收入,少数民族的高患病率。
规划补助金的总体目标有三个方面。首先,启动几项举措,进一步加强和鼓励坦普尔大学的多学科临床和转化研究。第二,正式成立一个新的坦普尔大学临床和转化科学中心。第三,为未来的NIH临床和转化科学奖(CTSA)制定一个有竞争力的提案。在此期间,天普大学将:1)调查和组织我们的研究生教育,博士后和奖学金培训,研究实验室设施和研究人员的专业领域的资源; 2)探索我们在基础科学,临床和转化研究的当前和未来的需求;第三章鼓励临床和转化研究以及多学科合作研究的研究人员,方法是召开会议,并开始撰写临床和转化研究通讯,以进一步告知教职员工,研究人员了解正在进行的研究项目,共享研究设备,改善研究基础设施和合作转化研究的机会; 4)概念化物理和人员基础设施,以创建临床研究和转化科学中心,以鼓励多学科研究; 5)为CTSA的应用奠定基础-为CTSA的内容、治理、管理和评估制定一项全面计划,并讨论实施CTSA以促进教育所需的组织和文化变革,临床和基础科学的培训和研究。
该中心将提供一个学术之家,以加强临床和转化科学,提高临床研究的效率,培养未来的临床和转化科学家,并促进临床和转化科学家的职业发展。该临床研究和转化科学中心将有助于鼓励生物医学科学的进步转化为面向患者的研究。该中心将提供所需的临床研究资源,并利用坦普尔大学位于城市地区的优势,为少数民族、肥胖、糖尿病、肺和心血管疾病高发人群提供服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HENRY PAUL PARKMAN其他文献
HENRY PAUL PARKMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HENRY PAUL PARKMAN', 18)}}的其他基金
Effects of COVID-19 in Patients with Gastroparesis: A GpCRC Supplement
COVID-19 对胃轻瘫患者的影响:GpCRC 补充剂
- 批准号:
10179037 - 财政年份:2006
- 资助金额:
$ 22.5万 - 项目类别:














{{item.name}}会员




